Use of metamizole in children and the risk of agranulocytosis
- 1 December 2015
- journal article
- comment
- Published by Ovid Technologies (Wolters Kluwer Health) in European Journal of Anaesthesiology
- Vol. 32 (12), 837-838
- https://doi.org/10.1097/eja.0000000000000275
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Metamizole for postoperative pain therapy in 1177 childrenEuropean Journal of Anaesthesiology, 2015
- Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reportsEuropean Journal of Clinical Pharmacology, 2014
- Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case–Control Surveillance StudyEuropean Journal of Clinical Pharmacology, 2014
- Drug-induced agranulocytosis in the Berlin case–control surveillance studyEuropean Journal of Clinical Pharmacology, 2013
- Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole)European Journal of Clinical Pharmacology, 2002
- Antithyroid Drug–Induced AgranulocytosisArchives of Internal Medicine, 1990
- DIPYRONE TRIALS IN THAILANDThe Lancet, 1989
- Immune‐mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodiesBritish Journal of Haematology, 1989
- Risks of Agranulocytosis and Aplastic AnemiaJAMA, 1986
- AGRANULOCYTIC LEUKOPENIA INDUCED BY A DRUG RELATED TO AMINOPYRINEJournal of the American Medical Association, 1936